| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
75,106 |
62,864 |
$4.69M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
43,741 |
37,008 |
$2.59M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,362 |
11,731 |
$1.48M |
| 80053 |
Comprehensive metabolic panel |
75,774 |
57,470 |
$1.47M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
39,919 |
10,823 |
$1.41M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
45,640 |
2,878 |
$1.17M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13,125 |
11,630 |
$1.17M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
13,542 |
11,724 |
$999K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,757 |
8,387 |
$599K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,425 |
5,335 |
$566K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,638 |
10,121 |
$550K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,219 |
2,964 |
$542K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
86,928 |
63,294 |
$526K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13,338 |
11,874 |
$513K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,209 |
8,091 |
$512K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,965 |
10,423 |
$430K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,007 |
6,288 |
$429K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
18,263 |
5,285 |
$384K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,372 |
4,823 |
$370K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,867 |
12,687 |
$342K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,052 |
5,224 |
$340K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,964 |
10,425 |
$338K |
| 97113 |
|
5,500 |
1,816 |
$306K |
| 80061 |
Lipid panel |
14,382 |
12,916 |
$294K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,815 |
1,693 |
$282K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,551 |
5,729 |
$277K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
10,411 |
9,019 |
$275K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,593 |
1,765 |
$270K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,694 |
5,170 |
$217K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,462 |
2,246 |
$200K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,095 |
10,619 |
$192K |
| G0378 |
Hospital observation service, per hour |
6,675 |
5,141 |
$183K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14,938 |
13,065 |
$174K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,656 |
2,375 |
$174K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,833 |
2,538 |
$166K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
3,652 |
3,373 |
$154K |
| 87481 |
|
3,324 |
2,734 |
$148K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12,471 |
11,181 |
$145K |
| 84484 |
|
18,775 |
12,512 |
$142K |
| 81025 |
|
19,396 |
16,622 |
$142K |
| 84702 |
|
4,921 |
3,343 |
$140K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,156 |
1,844 |
$137K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,467 |
10,072 |
$134K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,749 |
3,344 |
$134K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,369 |
1,234 |
$133K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,793 |
1,585 |
$126K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,202 |
2,716 |
$126K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,139 |
2,858 |
$125K |
| 0240U |
|
3,912 |
3,561 |
$122K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,720 |
4,185 |
$119K |
| 81001 |
|
35,705 |
30,609 |
$119K |
| 97162 |
|
4,073 |
3,365 |
$118K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
3,278 |
2,878 |
$117K |
| 82728 |
|
6,354 |
5,333 |
$117K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,338 |
1,605 |
$114K |
| 80050 |
General health panel |
5,527 |
4,948 |
$107K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,240 |
3,021 |
$103K |
| 76830 |
Ultrasound, transvaginal |
3,021 |
2,752 |
$101K |
| 82565 |
|
8,051 |
6,855 |
$99K |
| 71046 |
Radiologic examination, chest; 2 views |
18,822 |
16,526 |
$99K |
| 93976 |
|
2,677 |
2,390 |
$98K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,535 |
1,379 |
$96K |
| 87077 |
|
5,683 |
5,051 |
$94K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,019 |
929 |
$93K |
| 85027 |
|
9,295 |
7,725 |
$91K |
| 87088 |
|
14,923 |
13,052 |
$89K |
| 86140 |
|
20,079 |
16,415 |
$86K |
| 87653 |
|
1,784 |
1,587 |
$85K |
| 87634 |
|
1,440 |
1,292 |
$85K |
| 85610 |
|
12,765 |
9,567 |
$83K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,664 |
3,272 |
$82K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,383 |
1,240 |
$81K |
| 97161 |
|
2,126 |
1,811 |
$80K |
| 80081 |
|
883 |
751 |
$77K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,625 |
1,431 |
$77K |
| 84439 |
|
4,540 |
4,085 |
$76K |
| 82607 |
|
4,041 |
3,618 |
$75K |
| 83735 |
|
14,260 |
9,702 |
$73K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
388 |
367 |
$72K |
| 82950 |
|
2,009 |
1,799 |
$72K |
| 62323 |
|
541 |
461 |
$71K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,173 |
1,105 |
$69K |
| 80076 |
|
2,672 |
2,348 |
$68K |
| 93017 |
|
1,821 |
1,644 |
$66K |
| 83880 |
|
3,418 |
2,908 |
$64K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,009 |
354 |
$64K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,723 |
1,520 |
$64K |
| 83690 |
|
12,306 |
10,329 |
$63K |
| 12001 |
|
738 |
679 |
$62K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
405 |
310 |
$61K |
| 87480 |
|
2,678 |
2,360 |
$61K |
| 93971 |
|
2,087 |
1,882 |
$59K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,820 |
2,552 |
$58K |
| 82947 |
|
9,206 |
5,399 |
$58K |
| 59025 |
Fetal non-stress test |
725 |
330 |
$57K |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
7,598 |
566 |
$57K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
417 |
376 |
$55K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,335 |
1,086 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,154 |
1,002 |
$55K |
| 82805 |
|
2,523 |
2,118 |
$54K |
| 92557 |
|
946 |
868 |
$52K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
320 |
292 |
$51K |
| 87506 |
|
298 |
275 |
$48K |
| 87510 |
|
2,678 |
2,360 |
$47K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,566 |
2,237 |
$46K |
| 80074 |
|
905 |
786 |
$44K |
| 86481 |
|
527 |
482 |
$43K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
650 |
573 |
$42K |
| 86592 |
|
1,774 |
1,511 |
$41K |
| 87081 |
|
2,169 |
1,924 |
$39K |
| 85378 |
|
5,856 |
5,193 |
$39K |
| 88142 |
|
1,968 |
1,733 |
$37K |
| 94770 |
|
1,150 |
1,036 |
$37K |
| 82043 |
|
2,883 |
2,620 |
$37K |
| 82105 |
|
873 |
755 |
$37K |
| 80069 |
|
954 |
783 |
$36K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,110 |
9,329 |
$36K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,165 |
950 |
$35K |
| 76801 |
|
1,569 |
1,387 |
$34K |
| 87070 |
|
1,865 |
1,600 |
$33K |
| 93350 |
|
372 |
338 |
$33K |
| 83605 |
|
4,459 |
3,756 |
$31K |
| 96367 |
|
528 |
317 |
$31K |
| 87186 |
|
4,905 |
4,370 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
26,811 |
21,249 |
$30K |
| 87040 |
|
4,141 |
2,320 |
$28K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
65 |
37 |
$28K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
10,279 |
6,388 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,567 |
10,770 |
$28K |
| 73630 |
|
3,527 |
3,023 |
$27K |
| 82550 |
|
3,048 |
2,440 |
$26K |
| 86850 |
|
3,736 |
2,935 |
$26K |
| 84145 |
|
1,834 |
1,595 |
$26K |
| 83874 |
|
1,798 |
1,454 |
$24K |
| 72100 |
|
2,213 |
2,042 |
$23K |
| 12011 |
|
294 |
270 |
$23K |
| 76642 |
|
645 |
565 |
$23K |
| 85730 |
|
6,453 |
5,354 |
$23K |
| 71250 |
|
722 |
660 |
$22K |
| 88720 |
|
424 |
329 |
$22K |
| 0002A |
|
885 |
570 |
$22K |
| 85651 |
|
1,770 |
1,583 |
$22K |
| 97802 |
|
1,441 |
1,192 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
588 |
524 |
$21K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
70 |
55 |
$21K |
| 86803 |
|
1,855 |
1,641 |
$20K |
| 70486 |
|
662 |
613 |
$20K |
| 83540 |
|
3,695 |
3,106 |
$20K |
| 93970 |
|
564 |
515 |
$20K |
| 0001A |
|
900 |
580 |
$20K |
| 86762 |
|
1,241 |
1,069 |
$20K |
| 92567 |
|
1,201 |
1,089 |
$19K |
| 76536 |
|
469 |
434 |
$19K |
| 64493 |
|
113 |
86 |
$19K |
| 74150 |
|
344 |
314 |
$19K |
| 83550 |
|
3,402 |
2,880 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
236 |
119 |
$18K |
| 82746 |
|
1,603 |
1,417 |
$18K |
| 81002 |
|
4,770 |
4,299 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
465 |
408 |
$17K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
231 |
121 |
$17K |
| 10060 |
|
211 |
195 |
$17K |
| 84153 |
|
1,042 |
936 |
$17K |
| 84550 |
|
3,091 |
2,281 |
$16K |
| 87660 |
|
1,179 |
1,037 |
$16K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
459 |
111 |
$15K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,838 |
17,363 |
$15K |
| 12002 |
|
182 |
165 |
$15K |
| 70498 |
|
217 |
198 |
$15K |
| 87340 |
|
2,451 |
2,088 |
$15K |
| 70496 |
|
197 |
183 |
$15K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
408 |
329 |
$14K |
| 73030 |
|
2,374 |
2,111 |
$14K |
| 82784 |
|
678 |
521 |
$14K |
| 87210 |
|
2,343 |
2,099 |
$14K |
| 72141 |
|
244 |
225 |
$13K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,971 |
1,572 |
$13K |
| 85652 |
|
5,097 |
4,498 |
$13K |
| 91300 |
|
2,109 |
1,277 |
$13K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
681 |
614 |
$13K |
| 97166 |
|
635 |
491 |
$12K |
| 82553 |
|
1,774 |
1,433 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
647 |
567 |
$12K |
| 84100 |
|
4,491 |
2,427 |
$12K |
| 74018 |
|
1,382 |
1,190 |
$11K |
| 82948 |
|
2,605 |
2,252 |
$11K |
| 86901 |
|
4,989 |
3,913 |
$11K |
| 82247 |
|
398 |
222 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
37,612 |
29,035 |
$11K |
| 86900 |
|
4,415 |
3,425 |
$11K |
| 86480 |
|
215 |
200 |
$11K |
| 83516 |
|
925 |
756 |
$10K |
| 97803 |
|
500 |
362 |
$10K |
| 73562 |
|
3,103 |
2,707 |
$10K |
| 76770 |
|
224 |
195 |
$10K |
| 64494 |
|
67 |
49 |
$10K |
| 86038 |
|
977 |
837 |
$10K |
| 97116 |
|
881 |
437 |
$9K |
| 92595 |
|
179 |
146 |
$9K |
| 73610 |
|
2,851 |
2,533 |
$8K |
| 0003A |
|
262 |
181 |
$8K |
| 83970 |
|
1,087 |
753 |
$8K |
| C8923 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography |
107 |
99 |
$8K |
| 73130 |
|
2,280 |
1,968 |
$8K |
| 81003 |
|
3,165 |
2,772 |
$8K |
| J1756 |
Injection, iron sucrose, 1 mg |
6,481 |
2,492 |
$8K |
| 87493 |
|
247 |
223 |
$7K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,044 |
516 |
$7K |
| 36592 |
|
2,110 |
898 |
$7K |
| 83615 |
|
1,431 |
775 |
$7K |
| 64635 |
|
52 |
42 |
$7K |
| 0031A |
|
254 |
179 |
$7K |
| 64636 |
|
50 |
41 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
17 |
16 |
$7K |
| 84132 |
|
1,047 |
654 |
$7K |
| 87522 |
Neg quan hep c or qual rna |
194 |
166 |
$6K |
| 82150 |
|
460 |
412 |
$6K |
| 29125 |
|
143 |
135 |
$6K |
| 93356 |
|
83 |
77 |
$6K |
| 73502 |
|
1,297 |
1,177 |
$6K |
| 43249 |
|
39 |
31 |
$6K |
| 95806 |
|
98 |
93 |
$6K |
| 82010 |
|
899 |
737 |
$6K |
| 87420 |
|
345 |
310 |
$5K |
| 86039 |
|
590 |
516 |
$5K |
| 87205 |
|
1,840 |
1,576 |
$5K |
| 86430 |
|
1,135 |
1,000 |
$5K |
| 90715 |
|
969 |
889 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
8,744 |
7,614 |
$5K |
| 81511 |
|
55 |
46 |
$5K |
| 96415 |
|
66 |
38 |
$5K |
| 82677 |
|
204 |
186 |
$5K |
| 87075 |
|
685 |
582 |
$5K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
206 |
141 |
$5K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
6,526 |
2,009 |
$5K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
363 |
317 |
$4K |
| 99001 |
|
412 |
341 |
$4K |
| 80177 |
|
259 |
199 |
$4K |
| 93321 |
|
57 |
52 |
$4K |
| 84403 |
|
197 |
181 |
$4K |
| 82951 |
|
86 |
79 |
$4K |
| 90686 |
|
390 |
349 |
$4K |
| 71271 |
|
58 |
53 |
$4K |
| 73110 |
|
1,578 |
1,401 |
$3K |
| 86336 |
|
204 |
186 |
$3K |
| 77080 |
|
54 |
52 |
$3K |
| 82248 |
|
715 |
463 |
$3K |
| 84703 |
|
229 |
200 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
62 |
53 |
$3K |
| 74183 |
|
32 |
24 |
$3K |
| 43235 |
|
13 |
12 |
$3K |
| 86780 |
|
282 |
264 |
$3K |
| 93308 |
|
25 |
24 |
$3K |
| 70491 |
|
40 |
37 |
$3K |
| 93923 |
|
60 |
51 |
$3K |
| 85018 |
|
4,399 |
3,025 |
$3K |
| 92591 |
|
14 |
12 |
$3K |
| 84112 |
|
42 |
37 |
$2K |
| 86706 |
|
112 |
101 |
$2K |
| C8928 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report |
25 |
25 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
387 |
347 |
$2K |
| 72072 |
|
167 |
154 |
$2K |
| 93880 |
|
62 |
57 |
$2K |
| 73564 |
|
120 |
87 |
$2K |
| 88304 |
|
1,118 |
1,019 |
$2K |
| 73221 |
|
39 |
37 |
$2K |
| 73080 |
|
780 |
711 |
$2K |
| 29515 |
|
29 |
24 |
$2K |
| 88342 |
|
2,692 |
2,350 |
$2K |
| 91303 |
|
253 |
178 |
$2K |
| 92552 |
|
17 |
13 |
$2K |
| 83001 |
|
93 |
81 |
$2K |
| 84520 |
|
5,164 |
2,785 |
$2K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
28 |
26 |
$2K |
| 0124A |
|
74 |
40 |
$2K |
| 97597 |
|
23 |
12 |
$2K |
| 84480 |
|
99 |
91 |
$2K |
| 80164 |
|
89 |
68 |
$1K |
| 86618 |
|
52 |
49 |
$1K |
| 86160 |
|
83 |
76 |
$1K |
| 87324 |
|
102 |
89 |
$1K |
| 76942 |
|
129 |
97 |
$1K |
| 76870 |
|
26 |
25 |
$1K |
| 80175 |
|
25 |
24 |
$1K |
| 86665 |
|
33 |
31 |
$1K |
| 97165 |
|
44 |
31 |
$1K |
| 64488 |
|
45 |
43 |
$1K |
| 82274 |
|
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
81 |
61 |
$1K |
| 82952 |
|
100 |
91 |
$1K |
| 83655 |
|
43 |
39 |
$1K |
| 29130 |
|
14 |
12 |
$1K |
| 94010 |
|
53 |
52 |
$1K |
| 86317 |
|
222 |
150 |
$1K |
| 94642 |
|
28 |
28 |
$1K |
| 73140 |
|
887 |
834 |
$1K |
| 86308 |
|
70 |
66 |
$1K |
| 72050 |
|
127 |
117 |
$1K |
| 82533 |
|
16 |
12 |
$1K |
| 74230 |
|
13 |
13 |
$989.36 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
516 |
401 |
$967.22 |
| 76000 |
|
94 |
81 |
$934.85 |
| 84460 |
|
594 |
385 |
$920.23 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,788 |
11,667 |
$907.05 |
| 87449 |
|
124 |
109 |
$895.63 |
| 92555 |
|
21 |
16 |
$861.67 |
| 93225 |
|
25 |
25 |
$848.70 |
| 82310 |
|
577 |
281 |
$805.19 |
| 72110 |
|
27 |
20 |
$799.37 |
| 87899 |
|
62 |
29 |
$797.28 |
| 95886 |
|
12 |
12 |
$796.63 |
| 71101 |
|
488 |
443 |
$756.59 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,256 |
1,088 |
$752.57 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,081 |
1,183 |
$747.39 |
| 74022 |
|
711 |
640 |
$732.87 |
| 82140 |
|
47 |
37 |
$716.14 |
| 73590 |
|
408 |
352 |
$699.65 |
| 76999 |
|
29 |
26 |
$681.60 |
| 84155 |
|
608 |
404 |
$656.98 |
| 82378 |
|
31 |
25 |
$639.80 |
| 94060 |
|
26 |
24 |
$630.85 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
163 |
79 |
$629.15 |
| 82570 |
|
147 |
122 |
$575.03 |
| 86664 |
|
33 |
31 |
$573.99 |
| 96376 |
|
2,048 |
1,644 |
$564.36 |
| 86580 |
|
14 |
12 |
$563.16 |
| 94727 |
|
259 |
244 |
$552.66 |
| 87046 |
|
93 |
87 |
$544.53 |
| 0072A |
|
44 |
12 |
$522.65 |
| 86200 |
|
58 |
55 |
$513.74 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
349 |
327 |
$504.42 |
| 93325 |
|
41 |
40 |
$496.87 |
| 86663 |
|
33 |
31 |
$492.46 |
| 87015 |
|
50 |
47 |
$489.22 |
| 86235 |
|
14 |
14 |
$481.78 |
| 97163 |
|
14 |
12 |
$465.43 |
| 84165 |
|
59 |
50 |
$425.76 |
| 93296 |
|
40 |
39 |
$408.42 |
| 86735 |
|
48 |
41 |
$379.46 |
| 86765 |
|
48 |
41 |
$374.67 |
| 73090 |
|
95 |
82 |
$343.22 |
| 87147 |
|
82 |
72 |
$317.53 |
| 94729 |
|
276 |
260 |
$312.81 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,464 |
1,986 |
$304.85 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,957 |
2,346 |
$297.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12,504 |
9,437 |
$294.54 |
| 86225 |
|
27 |
27 |
$291.48 |
| 83883 |
|
13 |
12 |
$283.26 |
| 90656 |
|
34 |
34 |
$267.73 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
296 |
269 |
$252.17 |
| 86334 |
|
13 |
12 |
$248.45 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,462 |
3,640 |
$225.52 |
| 84156 |
|
89 |
77 |
$221.91 |
| 88307 |
|
104 |
72 |
$219.12 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,496 |
3,152 |
$170.83 |
| 86812 |
|
17 |
14 |
$163.91 |
| J2704 |
Injection, propofol, 10 mg |
8,493 |
6,115 |
$158.05 |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$154.76 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,969 |
3,098 |
$145.17 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,419 |
2,276 |
$142.84 |
| 76376 |
|
55 |
48 |
$135.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,144 |
8,796 |
$133.73 |
| 72170 |
|
64 |
60 |
$122.06 |
| J2785 |
Injection, regadenoson, 0.1 mg |
299 |
273 |
$120.44 |
| 73560 |
|
50 |
39 |
$104.83 |
| V2632 |
Posterior chamber intraocular lens |
437 |
340 |
$101.77 |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
24 |
14 |
$101.45 |
| 94760 |
|
1,512 |
1,338 |
$93.23 |
| 76998 |
|
119 |
96 |
$91.69 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,411 |
983 |
$86.81 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$86.66 |
| 84466 |
|
244 |
176 |
$77.70 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
128 |
88 |
$75.57 |
| 82040 |
|
400 |
231 |
$75.17 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
913 |
774 |
$70.21 |
| 51798 |
|
120 |
91 |
$62.86 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
57 |
46 |
$62.36 |
| 86923 |
|
45 |
24 |
$54.62 |
| 84295 |
|
410 |
237 |
$52.90 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,120 |
1,775 |
$49.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,198 |
794 |
$48.63 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,398 |
2,646 |
$46.39 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,906 |
6,477 |
$43.43 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,103 |
5,121 |
$42.25 |
| 82374 |
|
393 |
224 |
$41.22 |
| J2501 |
Injection, paricalcitol, 1 mcg |
23,475 |
1,807 |
$37.68 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,726 |
888 |
$20.82 |
| C1769 |
Guide wire |
205 |
177 |
$16.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,086 |
5,549 |
$15.74 |
| J1940 |
Injection, furosemide, up to 20 mg |
98 |
55 |
$12.57 |
| L1906 |
Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf |
389 |
360 |
$12.56 |
| V5266 |
Battery for use in hearing device |
16 |
13 |
$12.35 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
797 |
570 |
$11.61 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,919 |
1,119 |
$9.11 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,818 |
1,275 |
$7.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
567 |
287 |
$6.59 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
1,280 |
1,122 |
$6.25 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,299 |
1,825 |
$6.25 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,564 |
782 |
$5.86 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
568 |
503 |
$5.01 |
| J1453 |
Injection, fosaprepitant, 1 mg |
19 |
12 |
$2.77 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
632 |
562 |
$2.05 |
| J3480 |
Injection, potassium chloride, per 2 meq |
705 |
388 |
$1.49 |
| J2372 |
Injection, phenylephrine hydrochloride (biorphen), 20 micrograms |
45 |
42 |
$0.89 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
82 |
57 |
$0.50 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
17 |
15 |
$0.11 |
| 91312 |
|
68 |
38 |
$0.09 |
| 91305 |
|
25 |
16 |
$0.02 |
| 91307 |
|
51 |
14 |
$0.01 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
98 |
85 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
2,241 |
1,652 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
264 |
162 |
$0.00 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
25 |
24 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
148 |
117 |
$0.00 |
| 99406 |
|
67 |
67 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
46 |
40 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
59 |
50 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
43 |
31 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
34 |
28 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
892 |
219 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
63 |
57 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
242 |
94 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
77 |
48 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
17 |
12 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
33 |
25 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
46 |
36 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
33 |
25 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
17 |
16 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
92 |
75 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
26 |
26 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
25 |
21 |
$0.00 |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
14 |
14 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
15 |
12 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
16 |
13 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
339 |
241 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,696 |
1,186 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
152 |
137 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
59 |
48 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
280 |
223 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
272 |
210 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
295 |
122 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
30 |
27 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
13 |
12 |
$0.00 |
| C1776 |
Joint device (implantable) |
25 |
24 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
177 |
139 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
57 |
50 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
110 |
88 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
101 |
41 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
15 |
13 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
17 |
12 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
16 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
96 |
62 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
19 |
14 |
$0.00 |
| 51701 |
|
14 |
13 |
$0.00 |